Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells.

Edri A, Ben-Haim N, Hailu A, Brycman N, Berhani-Zipori O, Rifman J, Cohen S, Yackoubov D, Rosenberg M, Simantov R, Teru H, Kurata K, Anderson KC, Hendel A, Pato A, Geffen Y

Open source

DOI
10.3390/ijms242417231
Published
2023 Dec 7
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms242417231,
  title = {Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells.},
  author = {Edri A and Ben-Haim N and Hailu A and Brycman N and Berhani-Zipori O and Rifman J and Cohen S and Yackoubov D and Rosenberg M and Simantov R and Teru H and Kurata K and Anderson KC and Hendel A and Pato A and Geffen Y},
  year = {2023},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms242417231},
  url = {https://doi.org/10.3390/ijms242417231}
}

RIS

TY  - JOUR
TI  - Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells.
AU  - Edri A
AU  - Ben-Haim N
AU  - Hailu A
AU  - Brycman N
AU  - Berhani-Zipori O
AU  - Rifman J
AU  - Cohen S
AU  - Yackoubov D
AU  - Rosenberg M
AU  - Simantov R
AU  - Teru H
AU  - Kurata K
AU  - Anderson KC
AU  - Hendel A
AU  - Pato A
AU  - Geffen Y
PY  - 2023
JO  - International journal of molecular sciences
DO  - 10.3390/ijms242417231
UR  - https://doi.org/10.3390/ijms242417231
ER  - 

APA

A, E., N, B., A, H., N, B., O, B., J, R., S, C., D, Y., M, R., R, S., H, T., K, K., KC, A., A, H., A, P., & Y, G. (2023). Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells.. International journal of molecular sciences. https://doi.org/10.3390/ijms242417231

Source records